用於治療和診斷化學療法抗性癌症的組合物和方法

• 收藏
• 分享

专利权人:

F. Hoffmann-La Roche AG;豪夫邁．羅氏有限公司

发明人:

WANG, Yulei

申请号：

HK18102602.6

公开号：

HK1243141A

申请日:

2018.02.23

申请国别(地区):

HK

年份:

2018

代理人:

摘要：

The invention provides methods of using expression levels of one or more stroma signature genes as selection criteria for determining a patient with cancer that is chemotherapy-resistant who may benefit from a particular anti-cancer therapy, such as stroma-targeted therapy, anti-angiogenic therapy, and/or immunotherapy. The present invention also provides methods of using expression levels of one or more stroma signature genes as a selection criterion for treating cancer patients, such as ovarian cancer patients, with a stroma-targeted agent.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/